Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF) PPT slides of all figures Correction (v204,p2487) Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Chang, D. H. Articles by Dhodapkar, M. V. Search for Related Content PubMed PubMed Citation Articles by Chang, D. H. Articles by Dhodapkar, M. V. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Cancer Immunization Related Collections Related Article Social Bookmarking                      What's this?

Sustained expansion of NKT cells and antigen-specific T cells after injection of -galactosyl-ceramide loaded mature dendritic cells in cancer patients

¹ Laboratory of Tumor Immunology and Immunotherapy, The Rockefeller University
² Laboratory of Cellular Physiology and Immunology, The Rockefeller University
³ Memorial Sloan Kettering Cancer Center, New York, NY 10021
⁴ Baylor Institute of Immunology Research, Dallas, TX 75246
⁵ Pharmaceutical Division, Kirin Breweries Co. Ltd., 150-8011 Tokyo, Japan

CORRESPONDENCE Madhav V. Dhodapkar: dhodapm{at}rockefeller.edu

Natural killer T (NKT) cells are distinct glycolipid reactive innate lymphocytes that are implicated in the resistance to pathogens and tumors. Earlier attempts to mobilize NKT cells, specifically, in vivo in humans met with limited success. Here, we evaluated intravenous injection of monocyte-derived mature DCs that were loaded with a synthetic NKT cell ligand, -galactosyl-ceramide (-GalCer; KRN-7000) in five patients who had advanced cancer. Injection of -GalCer–pulsed, but not unpulsed, dendritic cells (DCs) led to >100-fold expansion of several subsets of NKT cells in all patients; these could be detected for up to 6 mo after vaccination. NKT activation was associated with an increase in serum levels of interleukin-12 p40 and IFN- inducible protein-10. In addition, there was an increase in memory CD8⁺ T cells specific for cytomegalovirus in vivo in response to -GalCer–loaded DCs, but not unpulsed DCs. These data demonstrate the feasibility of sustained expansion of NKT cells in vivo in humans, including patients who have advanced cancer, and suggest that NKT activation might help to boost adaptive T cell immunity in vivo.

Abbreviations used: -GalCer, -galactosyl-ceramide; ANA, antinuclear antibody; Flu-MP, influenza matrix peptide; ICS, intracellular cytokine secretion; IP, IFN-–inducible protein; MIP, macrophage inflammatory protein; RF, rheumatoid factor.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Article

Boosting innate immunity in cancer

Heather L. Van Epps
J. Exp. Med. 2005 201: 1353. [Full Text] [PDF]

This article has been cited by other articles:

• Zhang, Z., Cherryholmes, G., Shively, J. E. (2008). Neutrophil secondary necrosis is induced by LL-37 derived from cathelicidin. J. Leukoc. Biol. 84: 780-788 [Abstract] [Full Text]  
• Zhang, Z., Cherryholmes, G., Mao, A., Marek, C., Longmate, J., Kalos, M., Amand, R. P. ST., Shively, J. E. (2008). High Plasma Levels of MCP-1 and Eotaxin Provide Evidence for an Immunological Basis of Fibromyalgia. Exp. Biol. Med. 233: 1171-1180 [Abstract] [Full Text]  
• Moreno, M., Molling, J. W., von Mensdorff-Pouilly, S., Verheijen, R. H. M., Hooijberg, E., Kramer, D., Reurs, A. W., van den Eertwegh, A. J. M., von Blomberg, B. M. E., Scheper, R. J., Bontkes, H. J. (2008). IFN-{gamma}-Producing Human Invariant NKT Cells Promote Tumor-Associated Antigen-Specific Cytotoxic T Cell Responses. J. Immunol. 181: 2446-2454 [Abstract] [Full Text]  
• Biburger, M., Tiegs, G. (2008). Activation-induced NKT cell hyporesponsiveness protects from {alpha}-galactosylceramide hepatitis and is independent of active transregulatory factors. J. Leukoc. Biol. 84: 264-279 [Abstract] [Full Text]  
• Berzofsky, J. A., Terabe, M. (2008). NKT Cells in Tumor Immunity: Opposing Subsets Define a New Immunoregulatory Axis. J. Immunol. 180: 3627-3635 [Abstract] [Full Text]  
• Wen, H., Dou, Y., Hogaboam, C. M., Kunkel, S. L. (2008). Epigenetic regulation of dendritic cell-derived interleukin-12 facilitates immunosuppression after a severe innate immune response. Blood 111: 1797-1804 [Abstract] [Full Text]  
• Shimizu, K., Kurosawa, Y., Taniguchi, M., Steinman, R. M., Fujii, S.-i. (2007). Cross-presentation of glycolipid from tumor cells loaded with {alpha}-galactosylceramide leads to potent and long-lived T cell mediated immunity via dendritic cells. J. Exp. Med. 204: 2641-2653 [Abstract] [Full Text]  
• Chung, Y., Qin, H., Kang, C.-Y., Kim, S., Kwak, L. W., Dong, C. (2007). An NKT-mediated autologous vaccine generates CD4 T-cell dependent potent antilymphoma immunity. Blood 110: 2013-2019 [Abstract] [Full Text]  
• Adotevi, O., Vingert, B., Freyburger, L., Shrikant, P., Lone, Y.-C., Quintin-Colonna, F., Haicheur, N., Amessou, M., Herbelin, A., Langlade-Demoyen, P., Fridman, W. H., Lemonnier, F., Johannes, L., Tartour, E. (2007). B Subunit of Shiga Toxin-Based Vaccines Synergize with {alpha}-Galactosylceramide to Break Tolerance against Self Antigen and Elicit Antiviral Immunity. J. Immunol. 179: 3371-3379 [Abstract] [Full Text]  
• Ebensen, T., Link, C., Riese, P., Schulze, K., Morr, M., Guzman, C. A. (2007). A Pegylated Derivative of {alpha}-Galactosylceramide Exhibits Improved Biological Properties. J. Immunol. 179: 2065-2073 [Abstract] [Full Text]  
• Teng, M. W.L., Westwood, J. A., Darcy, P. K., Sharkey, J., Tsuji, M., Franck, R. W., Porcelli, S. A., Besra, G. S., Takeda, K., Yagita, H., Kershaw, M. H., Smyth, M. J. (2007). Combined Natural Killer T-Cell Based Immunotherapy Eradicates Established Tumors in Mice. Cancer Res. 67: 7495-7504 [Abstract] [Full Text]  
• Touma, M., Antonini, V., Kumar, M., Osborn, S. L., Bobenchik, A. M., Keskin, D. B., Connolly, J. E., Grusby, M. J., Reinherz, E. L., Clayton, L. K. (2007). Functional Role for I{kappa}BNS in T Cell Cytokine Regulation As Revealed by Targeted Gene Disruption. J. Immunol. 179: 1681-1692 [Abstract] [Full Text]  
• Chang, Y.-J., Huang, J.-R., Tsai, Y.-C., Hung, J.-T., Wu, D., Fujio, M., Wong, C.-H., Yu, A. L. (2007). Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids. Proc. Natl. Acad. Sci. USA 104: 10299-10304 [Abstract] [Full Text]  
• McCarthy, C., Shepherd, D., Fleire, S., Stronge, V. S., Koch, M., Illarionov, P. A., Bossi, G., Salio, M., Denkberg, G., Reddington, F., Tarlton, A., Reddy, B. G., Schmidt, R. R., Reiter, Y., Griffiths, G. M., van der Merwe, P. A., Besra, G. S., Jones, E. Y., Batista, F. D., Cerundolo, V. (2007). The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation. J. Exp. Med. 204: 1131-1144 [Abstract] [Full Text]  
• Spisek, R., Kukreja, A., Chen, L.-C., Matthews, P., Mazumder, A., Vesole, D., Jagannath, S., Zebroski, H. A., Simpson, A. J.G., Ritter, G., Durie, B., Crowley, J., Shaughnessy, J. D. Jr., Scanlan, M. J., Gure, A. O., Barlogie, B., Dhodapkar, M. V. (2007). Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy. J. Exp. Med. 204: 831-840 [Abstract] [Full Text]  
• Hermans, I. F., Silk, J. D., Gileadi, U., Masri, S. H., Shepherd, D., Farrand, K. J., Salio, M., Cerundolo, V. (2007). Dendritic Cell Function Can Be Modulated through Cooperative Actions of TLR Ligands and Invariant NKT Cells. J. Immunol. 178: 2721-2729 [Abstract] [Full Text]  
• Coquet, J. M., Kyparissoudis, K., Pellicci, D. G., Besra, G., Berzins, S. P., Smyth, M. J., Godfrey, D. I. (2007). IL-21 Is Produced by NKT Cells and Modulates NKT Cell Activation and Cytokine Production. J. Immunol. 178: 2827-2834 [Abstract] [Full Text]  
• Shimizu, K., Goto, A., Fukui, M., Taniguchi, M., Fujii, S.-i. (2007). Tumor Cells Loaded with {alpha}-Galactosylceramide Induce Innate NKT and NK Cell-Dependent Resistance to Tumor Implantation in Mice. J. Immunol. 178: 2853-2861 [Abstract] [Full Text]  
• van der Vliet, H. J.J., Balk, S. P., Exley, M. A. (2006). Natural Killer T Cell-Based Cancer Immunotherapy.. Clin. Cancer Res. 12: 5921-5923 [Full Text]  
• Motohashi, S., Ishikawa, A., Ishikawa, E., Otsuji, M., Iizasa, T., Hanaoka, H., Shimizu, N., Horiguchi, S., Okamoto, Y., Fujii, S.-i., Taniguchi, M., Fujisawa, T., Nakayama, T. (2006). A Phase I Study of In vitro Expanded Natural Killer T Cells in Patients with Advanced and Recurrent Non-Small Cell Lung Cancer. Clin. Cancer Res. 12: 6079-6086 [Abstract] [Full Text]  
• Banerjee, D. K., Dhodapkar, M. V., Matayeva, E., Steinman, R. M., Dhodapkar, K. M. (2006). Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients. Blood 108: 2655-2661 [Abstract] [Full Text]  
• Shimizu, K., Hidaka, M., Kadowaki, N., Makita, N., Konishi, N., Fujimoto, K., Uchiyama, T., Kawano, F., Taniguchi, M., Fujii, S.-i. (2006). Evaluation of the Function of Human Invariant NKT Cells from Cancer Patients Using {alpha}-Galactosylceramide-Loaded Murine Dendritic Cells.. J. Immunol. 177: 3484-3492 [Abstract] [Full Text]  
• Lizee, G., Radvanyi, L. G., Overwijk, W. W., Hwu, P. (2006). Improving Antitumor Immune Responses by Circumventing Immunoregulatory Cells and Mechanisms.. Clin. Cancer Res. 12: 4794-4803 [Abstract] [Full Text]  
• Fujii, S.-i., Shimizu, K., Hemmi, H., Fukui, M., Bonito, A. J., Chen, G., Franck, R. W., Tsuji, M., Steinman, R. M. (2006). Glycolipid {alpha}-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice. Proc. Natl. Acad. Sci. USA 103: 11252-11257 [Abstract] [Full Text]  
• Brutkiewicz, R. R. (2006). CD1d Ligands: The Good, the Bad, and the Ugly. J. Immunol. 177: 769-775 [Abstract] [Full Text]  
• Chang, D. H., Liu, N., Klimek, V., Hassoun, H., Mazumder, A., Nimer, S. D., Jagannath, S., Dhodapkar, M. V. (2006). Enhancement of ligand-dependent activation of human natural killer T cells by lenalidomide: therapeutic implications. Blood 108: 618-621 [Abstract] [Full Text]  
• Gadola, S. D., Koch, M., Marles-Wright, J., Lissin, N. M., Shepherd, D., Matulis, G., Harlos, K., Villiger, P. M., Stuart, D. I., Jakobsen, B. K., Cerundolo, V., Jones, E. Y. (2006). Structure and binding kinetics of three different human CD1d-{alpha}-galactosylceramide-specific T cell receptors. J. Exp. Med. 203: 699-710 [Abstract] [Full Text]  
• Munz, C., Steinman, R. M., Fujii, S.-i. (2005). Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. J. Exp. Med. 202: 203-207 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS